Chattem Appoints Riker VP R&D

January 14, 2002

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal


Chattem Appoints Riker VP R&D

CHATTANOOGA, Tenn.--Chattem Inc. (www.chattem.com)announced that Donald Riker, Ph.D., has been appointed vice president ofresearch & development and chief scientific officer. Riker has nearly 20years of leadership experience in clinical-regulatory affairs, licensing andinnovative OTC product development both at Richardson-Vicks and Procter &Gamble Healthcare. He is a member of several associations, including theAmerican Academy of Allergy, Asthma & Immunology and the American Societyfor Clinical Pharmacology & Therapeutics.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like